Top Markets
Coin of the day
Purple Biotech Ltd. Purple Biotech Ltd.

Purple Biotech Ltd.

PPBT
Classifica tra le azioni #40642
Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies... Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies for cancer patients in the United States, specifically addressing challenges like tumor immune evasion and drug resistance. Its diverse oncology pipeline includes CM24, a humanized monoclonal antibody that targets and blocks carcinoembryonic antigen related cell adhesion molecule 1 (CEACAM1). Currently in Phase 2 clinical trials, CM24 is being investigated as a combination therapy with anti-PD-1 checkpoint inhibitors for treating pancreatic ductal adenocarcinoma. Another candidate is NT219, a small molecule compound in Phase 1/2 clinical trials, which functions by inhibiting insulin receptor substrate 1 and 2 (IRS1/2) and signal transducer and activator of transcription (STAT). This compound is being developed for recurrent and/or metastatic squamous cell carcinoma of the head and neck, or colorectal adenocarcinoma. Furthermore, IM1240, a multi-valent antibody designed to activate an anti-tumoral immune response against 5T4-positive tumors, is in its preclinical stage. The company has established significant collaborations, including an agreement with Bristol Myers Squibb Company for Phase 2 clinical trials to assess CM24 in combination with the PD-1 inhibitor nivolumab and chemotherapy, as well as a partnership with Mor Research Applications. Formerly known as Kitov Pharma Ltd., the company adopted the name Purple Biotech Ltd. in December 2020 and is headquartered in Rehovot, Israel.
Prezzo delle azioni
$0.00323826
Ultima sincronizzazione: 2026-08-12
Capitalizzazione di mercato
$104.81K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-70.42%
Paese
IL
Scambia Purple Biotech Ltd. (PPBT)

Categoria

Storico del prezzo dell'azione per Purple Biotech Ltd. (PPBT)
Prezzo di chiusura più alto: $0.00 il 2026-08-01

Prezzo di chiusura più basso: $66.99K il 2002-08-01
Storico del prezzo dell'azione di Purple Biotech Ltd. dal 2002 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 0.00%
2025 -81.67%
2024 -77.97%
2023 -42.38%
2022 -58.58%
2021 -1.91%
2020 -42.76%
2019 -27.25%
2018 -53.94%
2017 -34.07%
2016 -2.83%
2015 -56.33%
2014 -90.72%
2013 19.75%
2012 -27.68%
2011 -56.00%
2010 -33.42%
2009 12.56%
2008 -95.78%
2007 7.52%
2006 9.91%
2005 47.91%
2004 -83.15%
2003 -65.07%
2002 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE